Trial Profile
Non-interventional Study on Long-term Application of Galantamine and Nootropics in Patients With Alzheimer's Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2014
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Ginkgo biloba; Nicergoline; Nootropics; Piracetam
- Indications Alzheimer's disease; Vascular dementia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen-Cilag
- 15 Nov 2009 New trial record